首页> 外文期刊>Journal of voice: official journal of the Voice Foundation >Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor
【24h】

Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor

机译:伴随患者痉挛性障碍症患者肉毒杆菌毒素给药的差异与基本语音震颤

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives To explore possible dose differences in average botulinum toxin (BTX) given to patients with adductor spasmodic dysphonia (ADSD) compared with patients with essential voice tremor (EVT). Methods A retrospective study compared the average BTX dose injected in equal doses to the thyroarytenoid (TA) muscles of 51 patients with ADSD with 52 patients with EVT. Results Those with ADSD received significantly higher total doses (6.80 ± 2.79 units) compared with those with EVT (5.02 ± 1.65 units). Dose at time of first injection, age at time of first injection, gender, year of first injection, and average time between injections were included in multivariate analysis but did not interact with total average dose findings. Conclusions Patients with ADSD may need relatively higher doses of BTX injections to bilateral TA muscles compared with patients with EVT.
机译:与基本语音震颤(EVT)的患者相比,探讨给予接和痉挛性障碍患者(ADSD)的患者的平均肉毒杆菌毒素(BTX)的可能剂量差异。 方法回顾性研究与51例ADSD患者的甲状腺内剂量(TA)肌肉相比,将平均BTX剂量与ADSD患者的甲状腺内乳肌(TA)肌肉进行比较。 结果与EVT(5.02±1.65单位)相比,含有ADSD的含量显着更高的总剂量(6.80±2.79单位)。 在第一次注射时的剂量,第一次注射时的年龄,性别,第一次注射年份,注射之间的平均时间包括在多变量分析中,但没有与总平均剂量结果相互作用。 与EVT患者相比,患有ADSD的患者可能需要对双侧TA肌肉进行相对较高的BTX注射。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号